Strategic partnerships IIAM already maintains broad collaborations with organ procurement organizations and research institutions, including recent ties with Platinum Training and Ambys. Leverage these networks to position complementary sourcing, processing, or analytical services that enhance donor tissue utility and accelerate pre-clinical studies.

Non-transplant tissue focus Specialization in non-transplantable organs for research presents a niche opportunity for high-value services such as tissue preservation, cell isolation, and diagnostic quality control. Propose scalable workflows, biobanking, and contract research support aimed at maximizing donor tissue utility for metabolic disorder research.

Growth through tech IIAM’s tech stack includes iCIMS, WordPress, Google Cloud, and security tools like Barracuda and KnowBe4. Offer enterprise-grade data integration, secure sample tracking, and cloud-based collaboration platforms to streamline referrals, screening, and placement processes and reduce cycle times.

Expansion signals Headcount growth and leadership appointments noted in 2020–2021 indicate scalability and evolving operations. Target IIAM for recruitment-enabling services, training programs, and consulting to support rapid onboarding, SOP development, and process optimization as they scale.

Funding range With revenue in the 10–25 million range and a nonprofit structure, IIAM may prioritize cost-effective, high-impact partnerships. Propose value-driven, risk-shared pilot projects, grant-aligned research services, and flexible pricing models that align with nonprofit budgeting cycles.